These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 27815069)
1. MicroRNA-542-3p inhibits the growth of hepatocellular carcinoma cells by targeting FZD7/Wnt signaling pathway. Wu W; Dang S; Feng Q; Liang J; Wang Y; Fan N Biochem Biophys Res Commun; 2017 Jan; 482(1):100-105. PubMed ID: 27815069 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling. Quan H; Li B; Yang J Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-613 represses prostate cancer cell proliferation and invasion through targeting Frizzled7. Ren W; Li C; Duan W; Du S; Yang F; Zhou J; Xing J Biochem Biophys Res Commun; 2016 Jan; 469(3):633-8. PubMed ID: 26703210 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-485-5p represses melanoma cell invasion and proliferation by suppressing Frizzled7. Wu J; Li J; Ren J; Zhang D Biomed Pharmacother; 2017 Jun; 90():303-310. PubMed ID: 28364602 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA DSCR8 acts as a molecular sponge for miR-485-5p to activate Wnt/β-catenin signal pathway in hepatocellular carcinoma. Wang Y; Sun L; Wang L; Liu Z; Li Q; Yao B; Wang C; Chen T; Tu K; Liu Q Cell Death Dis; 2018 Aug; 9(9):851. PubMed ID: 30154476 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma. Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/β-catenin signaling in human hepatocellular carcinoma. Zeng XC; Liu FQ; Yan R; Yi HM; Zhang T; Wang GY; Li Y; Jiang N Mol Cancer; 2014 Dec; 13():261. PubMed ID: 25491321 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-142-3p inhibits cell proliferation and invasion of cervical cancer cells by targeting FZD7. Deng B; Zhang Y; Zhang S; Wen F; Miao Y; Guo K Tumour Biol; 2015 Sep; 36(10):8065-73. PubMed ID: 25976503 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-381 suppresses cell growth and invasion by targeting the liver receptor homolog-1 in hepatocellular carcinoma. Zhang Q; Zhao S; Pang X; Chi B Oncol Rep; 2016 Mar; 35(3):1831-40. PubMed ID: 26677080 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-27b inhibits cell proliferation in oral squamous cell carcinoma by targeting FZD7 and Wnt signaling pathway. Liu B; Chen W; Cao G; Dong Z; Xu J; Luo T; Zhang S Arch Oral Biol; 2017 Nov; 83():92-96. PubMed ID: 28735227 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway. Bai Z; Xia X; Lu J Med Sci Monit; 2020 Jan; 26():e919241. PubMed ID: 31955177 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4). Wang G; Sun Y; He Y; Ji C; Hu B; Sun Y Int J Clin Exp Pathol; 2015; 8(1):337-44. PubMed ID: 25755720 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-582-3p targeting ribonucleotide reductase regulatory subunit M2 inhibits the tumorigenesis of hepatocellular carcinoma by regulating the Wnt/β-catenin signaling pathway. Xu H; Li B Bioengineered; 2022 May; 13(5):12876-12887. PubMed ID: 35609318 [TBL] [Abstract][Full Text] [Related]
15. MiR-24-3p enhances cell growth in hepatocellular carcinoma by targeting metallothionein 1M. Dong X; Ding W; Ye J; Yan D; Xue F; Xu L; Yin J; Guo W Cell Biochem Funct; 2016 Oct; 34(7):491-496. PubMed ID: 27650047 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-542-3p functions as a tumor suppressor via directly targeting survivin in hepatocellular carcinoma. Wang XP; Yao J; Guan J; Zhou ZQ; Zhang ZY; Yang J Biomed Pharmacother; 2018 Mar; 99():817-824. PubMed ID: 29710480 [TBL] [Abstract][Full Text] [Related]
17. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells. Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051 [TBL] [Abstract][Full Text] [Related]
18. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway. Cao F; Yin LX Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797 [TBL] [Abstract][Full Text] [Related]
19. miR-217 targeting DKK1 promotes cancer stem cell properties via activation of the Wnt signaling pathway in hepatocellular carcinoma. Jiang C; Yu M; Xie X; Huang G; Peng Y; Ren D; Lin M; Liu B; Liu M; Wang W; Kuang M Oncol Rep; 2017 Oct; 38(4):2351-2359. PubMed ID: 28849121 [TBL] [Abstract][Full Text] [Related]
20. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]